Literature DB >> 9278605

Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist.

D H Walker1, J S Dumler.   

Abstract

Human monocytic ehrlichiosis and human granulocytic ehrlichiosis are emerging tick-borne infections in the United States. The clinical presentations of these two distinct, potentially life-threatening infections are fever, headache, myalgia, and other diagnostically nonspecific symptoms. Physician awareness is lacking and appropriate diagnostic tests are still not widely available. Because few documented cases have been autopsied, the pathology of human monocytic ehrlichiosis and human granulocytic ehrlichiosis is incompletely described. In human monocytic ehrlichiosis, bone marrow and hepatic granulomas and multiorgan perivascular lymphohistiocytic infiltrates have been observed. In human granulocytic ehrlichiosis, opportunistic fungal and viral infections have been important findings. To expedite an analysis of the pathology and pathogenesis of the human ehrlichioses, it is proposed that a Registry of Pathology of Human Ehrlichioses be established.

Entities:  

Mesh:

Year:  1997        PMID: 9278605

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  36 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.

Authors:  Kum Thong Wong; Wun-Ju Shieh; Shalini Kumar; Karim Norain; Wahidah Abdullah; Jeannette Guarner; Cynthia S Goldsmith; Kaw Bing Chua; Sai Kit Lam; Chong Tin Tan; Khean Jin Goh; Heng Thay Chong; Rani Jusoh; Pierre E Rollin; Thomas G Ksiazek; Sherif R Zaki
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Anaplasma phagocytophilum infection induces protracted neutrophil degranulation.

Authors:  Kyoung-seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 4.  Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

Authors:  David H Walker; Nahed Ismail; Juan P Olano; Jere W McBride; Xue-Jie Yu; Hui-Min Feng
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

5.  Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway.

Authors:  Kyoung-Seong Choi; Joon Tae Park; J Stephen Dumler
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

7.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

8.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

9.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock.

Authors:  Qin Yang; Purnima Ghose; Nahed Ismail
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.